These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8270588)

  • 1. Use of low-dose fluoxetine in major depression and panic disorder.
    Louie AK; Lewis TB; Lannon RA
    J Clin Psychiatry; 1993 Nov; 54(11):435-8. PubMed ID: 8270588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open-label trial of nefazodone in high comorbidity panic disorder.
    DeMartinis NA; Schweizer E; Rickels K
    J Clin Psychiatry; 1996 Jun; 57(6):245-8. PubMed ID: 8666561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open prospective trial of fluoxetine for posttraumatic stress disorder.
    Nagy LM; Morgan CA; Southwick SM; Charney DS
    J Clin Psychopharmacol; 1993 Apr; 13(2):107-13. PubMed ID: 8463442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoxetine once every third day in the treatment of major depressive disorder.
    Tural U; Onder E
    Eur Arch Psychiatry Clin Neurosci; 2003 Dec; 253(6):307-12. PubMed ID: 14714120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapse in patients on long-term fluoxetine treatment: response to increased fluoxetine dose.
    Fava M; Rappe SM; Pava JA; Nierenberg AA; Alpert JE; Rosenbaum JF
    J Clin Psychiatry; 1995 Feb; 56(2):52-5. PubMed ID: 7852252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poor response to fluoxetine: underlying depression, serotonergic overstimulation, or a "therapeutic window"?
    Cain JW
    J Clin Psychiatry; 1992 Aug; 53(8):272-7. PubMed ID: 1500403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoxetine in panic disorder: pharmacologic and tritiated platelet imipramine and paroxetine binding study.
    Pecknold JC; Luthe L; Iny L; Ramdoyal D
    J Psychiatry Neurosci; 1995 May; 20(3):193-8. PubMed ID: 7786880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What constitutes an adequate antidepressant trial for fluoxetine?
    Schweizer E; Rickels K; Amsterdam JD; Fox I; Puzzuoli G; Weise C
    J Clin Psychiatry; 1990 Jan; 51(1):8-11. PubMed ID: 2403998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A fixed-dose clinical trial of fluoxetine in outpatients with major depression.
    Fabre LF; Putman HP
    J Clin Psychiatry; 1987 Oct; 48(10):406-8. PubMed ID: 3312176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous major depression and panic disorder: treatment with electroconvulsive therapy.
    Figiel GS; Zorumski CF; Doraiswamy PM; Mattingly GW; Jarvis MR
    J Clin Psychiatry; 1992 Jan; 53(1):12-5. PubMed ID: 1737733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoxetine and desipramine in major depressive disorder.
    Bowden CL; Schatzberg AF; Rosenbaum A; Contreras SA; Samson JA; Dessain E; Sayler M
    J Clin Psychopharmacol; 1993 Oct; 13(5):305-11. PubMed ID: 8227488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
    Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
    Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Panic disorder: treatment with valproate.
    Woodman CL; Noyes R
    J Clin Psychiatry; 1994 Apr; 55(4):134-6. PubMed ID: 8071256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenomenology and severity of major depression and comorbid lifetime anxiety disorders in primary medical care practice.
    Brown C; Schulberg HC; Shear MK
    Anxiety; 1996; 2(5):210-8. PubMed ID: 9160625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatient settings.
    Zajecka JM
    J Clin Psychiatry; 1996; 57 Suppl 2():10-4. PubMed ID: 8626357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion.
    Walker PW; Cole JO; Gardner EA; Hughes AR; Johnston JA; Batey SR; Lineberry CG
    J Clin Psychiatry; 1993 Dec; 54(12):459-65. PubMed ID: 8276736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoxetine treatment of dysthymia in the elderly.
    Nobler MS; Devanand DP; Kim MK; Fitzsimons LM; Singer TM; Turret N; Sackeim HA; Roose SP
    J Clin Psychiatry; 1996 Jun; 57(6):254-6. PubMed ID: 8666563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two dosage regimens of fluoxetine in major depression.
    Rickels K; Smith WT; Glaudin V; Amsterdam JB; Weise C; Settle GP
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):38-41. PubMed ID: 3882680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open trial of fluvoxamine therapy for panic disorder complicated by depression.
    Spiegel DA; Saeed SA; Bruce TJ
    J Clin Psychiatry; 1996; 57 Suppl 8():37-40; discussion 40-1. PubMed ID: 8698679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eighteen months of drug treatment for depression: predicting relapse and recovery.
    Mulder RT; Frampton CM; Luty SE; Joyce PR
    J Affect Disord; 2009 Apr; 114(1-3):263-70. PubMed ID: 18805590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.